LiveWire Ergogenics, Inc.
LVVV · OTC
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | 0.00 | -0.15 |
| FCF Yield | 0.00% | 0.00% | 2.08% | 1.91% |
| EV / EBITDA | 0.00 | 58.37 | 71.22 | 50.14 |
| Quality | ||||
| ROIC | 0.00% | 1.28% | -0.08% | 0.62% |
| Gross Margin | 0.00% | 93.52% | 92.54% | 94.81% |
| Cash Conversion Ratio | 1.72 | 1.17 | 0.70 | 0.92 |
| Growth | ||||
| Revenue 3-Year CAGR | -26.90% | -10.47% | 5.38% | 24.28% |
| Free Cash Flow Growth | 0.00% | 0.00% | 5.04% | -59.33% |
| Safety | ||||
| Net Debt / EBITDA | 0.00 | 36.65 | 35.12 | 24.24 |
| Interest Coverage | 0.00 | 0.81 | -0.12 | 0.56 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | -12,319.34 | -11,549.04 | -13,707.62 |